FDA Inspection 1254251 — USAntibiotics LLC
The FDA completed an inspection of USAntibiotics LLC on October 17, 2024 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 17, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Bristol, TN (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)